AI-driven platform to program delivery across biological barriers: cell membranes, BBB, and nuclear envelopes
Delivering therapeutics across biological barriers remains a critical bottleneck
Current delivery approaches are inefficient, restricting therapeutic potential
Lack of targeting mechanisms leads to off-target effects and reduced efficacy
Trial-and-error design approaches are expensive and time-consuming
Integrated AI system combining computation, biology, and high-throughput experimentation
Machine learning models predict optimal delivery mechanisms across biological barriers
Engineered systems for crossing cell membranes, BBB, and nuclear envelopes
Accelerated design-build-test cycles through automation and AI guidance
Continuous feedback from experimental results improves predictions
Bridging computational predictions with experimental validation
Targeting critical unmet medical needs
Crossing the blood-brain barrier for neurodegenerative diseases
Targeted delivery to cardiac tissue for regenerative therapies
Nuclear delivery of gene editors and regulators
Interested in collaboration or learning more about our platform?